Renowned global operations and manufacturing executive will drive excellence and scale business to meet growing demand for the company’s Molecular Cartography™ system MONHEIM AM RHEIN, Germany – Resolve Biosciences, the pioneer in Molecular Cartography™, today announced the appointment of Oliver Dick, PhD, as Chief Operating Officer. In this role, Dick will report to Co-founder and CEO […]
– A single-cell analysis solution that revolutionizes efficiency in drug discovery research by automating the collection of specific cells and intracellular components – Tokyo, Japan – December 1, 2021 Yokogawa Electric Corporation (TOKYO: 6841) announces that it has developed the Single Cellome™ System SS2000, a single-cell analysis solution that utilizes high-resolution images captured with a […]
New center brings local cell culture media optimization support for vaccines, advanced therapies, and biotherapeutic drug development SANTA ANA, California — FUJIFILM Irvine Scientific, Inc., a world leader in the development and manufacture of serum-free and chemically defined cell culture media for bioproduction and cell therapy manufacturing, today announced the establishment of an Innovation and Collaboration […]
FCDE to become the new majority shareholder of Bertin Technologies, today a subsidiary of the CNIM group, alongside the management team led by Bruno Vallayer. This new investment aims at supporting Bertin Technologies’ development to establish the group as a prominent independent equipment manufacturer and a consolidation plateform of advanced technologies. Paris FCDE announces the […]
TOKYO – PHCbi, the Biomedical Division of PHC Corporation and a global provider of laboratory and medical support equipment and services in the life sciences field, today introduced a new line of fixed-bed bioreactors manufactured by Univercells Technologies S.A. to the Japanese market. The scale-XTM bioreactors portfolio will enable scientists and researchers developing therapies in Japan […]
We are pleased to see that the jury invalidated the claim of United States Patent No. 7,541,444 asserted by Illumina in the trial in the Northern District of California. This patent contained the broadest of all the asserted claims and had the longest remaining life of the five asserted patents. With this result, MGI may potentially […]
Nanopore Community Meeting, Oxford, UK Highlights include release of new “Kit 12” and R10.4 flow cells for >Q20 (>99%) raw read and around Q30 (99.9%) Duplex sequencing accuracy, and the new PromethION P2 device, a palm-sized, high-throughput sequencer that delivers the most accessible low-cost, high-output Oxford Nanopore sequencer Oxford Nanopore has provided a technology update at its Nanopore Community Meeting, describing a range of product releases and upgrades. These […]
On December 1, 2021, the production site in Laage formerly belonging to Flamm Aerotec GmbH will see a new owner moving in: Miltenyi Biotec B.V. & Co. KG. With this acquisition, this globally operating biomedical company is expanding its capacities in the State of Mecklenburg-West Pomerania and is planning to create new jobs in the […]
On December 1, 2021, the production site in Laage formerly belonging to Flamm Aerotec GmbH will see a new owner moving in: Miltenyi Biotec B.V. & Co. KG. With this acquisition, this globally operating biomedical company is expanding its capacities in the State of Mecklenburg-West Pomerania and is planning to create new jobs in the […]
Growing CRISPR genome editing portfolio supports researchers on path to future therapeutic applications CARLSBAD, Calif. — For research applications requiring highly precise genome editing, including engineering CAR T cells and creating cellular models for disease discovery, the Invitrogen TrueCut HiFi Cas9 Protein* significantly minimizes off-target events while retaining maximum on-target editing efficiency. Thermo Fisher Scientific introduced the […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
